sThesis GmbH

sThesis is a start-up committed to develop and commercialize next generation optical devices to measure metabolites in blood with highest sensitivity and accuracy. The initial focus is on non-invasive glucose monitoring in patients diagnosed with diabetes. sThesis primary guiding principle is to provide solutions combining convenience and compliance with all medical and regulatory requirements, finally to improve patient’s quality of life.